Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)

Anna E. Coghill, Ruth M. Pfeiffer, Carla Proietti, Wan Lun Hsu, Yin Chu Chien, Lea Lekieffre, Lutz Krause, Andy Teng, Jocelyn Pablo, Kelly J. Yu, Pei Jen Lou, Cheng Ping Wang, Zhiwei Liu, Chien Jen Chen, Jaap Middeldorp, Jason Mulvenna, Jeff Bethony, Allan Hildesheim, Denise L. Doolan

Research output: Contribution to journalComment/Letter to the editorAcademic


In the original version of this article (1), the left panel of Fig. 2 was incorrectly labeled: the BFRF1 IgG antibody was incorrectly labeled as the BALF2 IgG antibody, and the corresponding sentence in the text was also incorrect. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.

Original languageEnglish
Pages (from-to)3496
Number of pages1
JournalClinical cancer research : an official journal of the American Association for Cancer Research
Issue number13
Publication statusPublished - 1 Jul 2020

Cite this